BIB

ProShares - Ultra Nasdaq BiotechnologyProShares

$80.08-3.89 (-4.63%)Close

AUM$86.8M

Expense Ratio1.19%

NAV$85.11

Holdings274

InceptionApr 7, 2010

Price Chart

Key Statistics

Previous Close

$83.97

Day Range

$79.26$81.59

52-Week Range

$36.99$88.17

Avg Volume

11.7K

Dividend Yield

0.75%

Expense Ratio

1.19%

AUM

$86.8M

Shares Outstanding

839.0K

Sector Breakdown

Sector	Weight %
Healthcare	100.00%

Country Allocation

Country	Weight %
United States	60.96%
Other	31.64%
United Kingdom	1.37%
Netherlands	1.35%
France	0.96%
Ireland	0.92%
Denmark	0.86%
Germany	0.54%
Canada	0.50%
Switzerland	0.31%
Singapore	0.12%
Bermuda	0.11%
Jersey	0.08%
Iceland	0.07%
Spain	0.06%
Cayman Islands	0.04%
China	0.04%
Australia	0.04%
Israel	0.03%
Belgium	0.03%
Taiwan (Province of China)	0.01%

Fund Information

Issuer: ProShares
Category: Healthcare
Subcategory: Biotech
Inception Date: Apr 7, 2010
Exchange: NASDAQ
Description: ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.

Similar ETFs

Symbol	Name	AUM	Expense Ratio	Holdings
IWM	iShares Russell 2000 ETF	$70.17B	0.19%	1,934
XLV	State Street Health Care Select Sector SPDR ETF	$40.61B	0.08%	60
VHT	Vanguard Health Care ETF	$19.80B	0.09%	411
COWZ	Pacer US Cash Cows 100 ETF	$18.40B	0.49%	103
VTWO	Vanguard Russell 2000 ETF	$14.50B	0.06%	1,969

The ProShares - Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund issued by ProShares that launched on Apr 7, 2010. It currently manages $86.8M in assets under management. The fund charges an expense ratio of 1.19%. The fund holds 274 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 62.8% of the fund

Rank	Symbol	Name	Weight %	Shares	Market Value
1	—	Net Other Assets (Liabilities)	31.94%	27,729,832	$27.7M
2	GILD	GILEAD SCIENCES INC	6.64%	38,798	$5.8M
3	VRTX	VERTEX PHARMACEUTICALS INC	6.47%	11,259	$5.6M
4	AMGN	AMGEN INC	6.11%	14,134	$5.3M
5	REGN	REGENERON PHARMACEUTICALS	4.12%	4,637	$3.6M
6	ALNY	ALNYLAM PHARMACEUTICALS INC	2.20%	5,931	$1.9M
7	INSM	INSMED INC	1.59%	9,574	$1.4M
8	BIIB	BIOGEN INC	1.43%	6,586	$1.2M
9	UTHR	UNITED THERAPEUTICS CORP	1.19%	1,932	$1.0M
10	ARGX	ARGENX SE - ADR	1.12%	1,306	$970K
11	MRNA	MODERNA INC	1.11%	17,539	$964K
12	ROIV	ROIVANT SCIENCES LTD	1.07%	31,224	$927K
13	RPRX	ROYALTY PHARMA PLC- CL A	1.02%	19,183	$882K
14	RVMD	REVOLUTION MEDICINES INC	0.99%	8,679	$858K
15	INCY	INCYTE CORP	0.97%	8,813	$846K

Page 1 of 6

Detailed Returns

Period	ETF	Cat. Avg
1D	-4.63%	—
1W	-2.36%	—
1M	-0.19%	—
3M	+4.64%	—
6M	+48.46%	—
YTD	+7.84%	—
1Y	+59.72%	—
3Y	+63.87%	—
5Y	-8.23%	—

Moving Averages

20-Day MA

$85.38

Below 20-Day MA

50-Day MA

$84.07

Below 50-Day MA

200-Day MA

$64.07

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$88.17

Current Price

$80.08

52-Week Low

$36.99

$36.99$88.17

Current Yield

0.75%

Annual Dividend

$0.6167

Frequency

4x/year

Last Ex-Date

Dec 24, 2025

Dividend History

Ex-Date	Amount	Pay Date
Dec 24, 2025	$0.1346	Dec 31, 2025
Sep 24, 2025	$0.1805	Sep 30, 2025
Jun 25, 2025	$0.1706	Jul 1, 2025
Mar 26, 2025	$0.1309	Apr 1, 2025
Dec 23, 2024	$0.3964	Dec 31, 2024
Sep 25, 2024	$0.1528	Oct 2, 2024
Jun 26, 2024	$0.2648	Jul 3, 2024
Mar 20, 2024	$0.0403	Mar 27, 2024
Dec 20, 2023	$0.0384	Dec 28, 2023
Dec 22, 2022	$0.0199	Dec 30, 2022
Sep 21, 2010	$0.0878	Sep 28, 2010

Dividend Payments Over Time

Category Comparison

Metric	BIB	Healthcare(223 ETFs)	Biotech(39 ETFs)
Fund Info
Expense Ratio	1.19%	0.60%	0.84%
AUM	$86.8M	$1.25B	$1.62B
Dividend Yield	0.75%	2.75%	14.38%
Avg Volume	11.7K	769.9K	1.3M
Holdings	274	182	67
Performance
1-Month Return	—	-3.02%	-2.05%
6-Month Return	—	+5.85%	+15.05%
YTD Return	—	+0.17%	+1.05%
1-Year Return	—	+16.65%	+24.43%

Compare with Another ETF

Search for an ETF to compare with BIB: